Prestige Consumer Healthcare Inc (PBH) Stake Increased by Legal & General Group Plc

Legal & General Group Plc grew its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 2.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 52,367 shares of the company’s stock after buying an additional 1,251 shares during the period. Legal & General Group Plc owned 0.10% of Prestige Consumer Healthcare worth $1,618,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 4.0% in the 4th quarter. BlackRock Inc. now owns 6,457,359 shares of the company’s stock valued at $199,402,000 after buying an additional 248,243 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Prestige Consumer Healthcare by 11.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,049,957 shares of the company’s stock valued at $125,062,000 after buying an additional 420,265 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Prestige Consumer Healthcare by 9.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,030,923 shares of the company’s stock valued at $114,842,000 after buying an additional 255,561 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Prestige Consumer Healthcare by 23.3% in the 4th quarter. Acadian Asset Management LLC now owns 1,235,502 shares of the company’s stock valued at $38,153,000 after buying an additional 233,793 shares in the last quarter. Finally, Macquarie Group Ltd. boosted its holdings in shares of Prestige Consumer Healthcare by 26.7% in the 3rd quarter. Macquarie Group Ltd. now owns 1,229,755 shares of the company’s stock valued at $46,595,000 after buying an additional 259,248 shares in the last quarter.

A number of research firms have recently weighed in on PBH. Zacks Investment Research upgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a report on Tuesday, April 16th. Desjardins cut shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 price target on the stock. in a report on Wednesday, February 13th. ValuEngine lowered shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, January 10th. Raymond James lowered shares of Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 price objective for the company. in a research report on Tuesday, January 15th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $97.00 price objective on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $54.07.

Shares of Prestige Consumer Healthcare stock opened at $28.08 on Friday. The company has a market capitalization of $1.45 billion, a P/E ratio of 10.88, a P/E/G ratio of 1.60 and a beta of 0.98. The company has a quick ratio of 1.34, a current ratio of 2.28 and a debt-to-equity ratio of 1.49. Prestige Consumer Healthcare Inc has a 52 week low of $26.25 and a 52 week high of $41.76.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.02. The firm had revenue of $241.40 million during the quarter, compared to analyst estimates of $241.40 million. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. Prestige Consumer Healthcare’s revenue was down 10.8% on a year-over-year basis. During the same period last year, the firm posted $0.70 EPS. Analysts expect that Prestige Consumer Healthcare Inc will post 2.77 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Prestige Consumer Healthcare Inc (PBH) Stake Increased by Legal & General Group Plc” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2019/04/21/prestige-consumer-healthcare-inc-pbh-stake-increased-by-legal-general-group-plc.html.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: Stock Symbols, CUSIP and Other Stock Identifiers

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.